SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
165 hedge funds and large institutions have $1.88B invested in Sage Therapeutics in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 47 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
9% more capital invested
Capital invested by funds: $1.72B → $1.88B (+$154M)
9% more funds holding
Funds holding: 152 → 165 (+13)
7% less call options, than puts
Call options by funds: $29.4M | Put options by funds: $31.7M
Holders
165
Holding in Top 10
6
Calls
$29.4M
Puts
$31.7M
Top Buyers
| 1 | +$59.1M | |
| 2 | +$29.3M | |
| 3 | +$11.8M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.52M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.78M |
Top Sellers
| 1 | -$61M | |
| 2 | -$22.8M | |
| 3 | -$18.6M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$14.6M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$13.5M |